ArticleThoracic cancer2024

Second malignancy in advanced or recurrent non-small cell lung cancer after the advent of molecular targeted drugs and immunotherapy.

Yoshihiro Masui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.